Market cap
$1,005 Mln
Revenue (TTM)
$1 Mln
P/E Ratio
--
P/B Ratio
5.2
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | 34.57 | -- | -- |
| EBIT | 22.17 | 40.78 | 31.07 | -8.82 | -301.85 |
| Net Profit | 15.41 | 35.24 | 30.10 | -6.09 | -295.02 |
| EPS | 15.53 | 35.81 | 36.65 | 5.40 | -- |
| Book Value | -- | -- | -13.11 | -15.31 | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-24 | Dec-23 |
| EBIT-Margin
| -- | -- | -7,919.68 | -- | -- |
| Net Margin
| -2,302.04 | -897.24 | -7,362.36 | -- | -- |
| Return on equity
| -51.03 | -11.69 | -50.41 | -54.27 | -64.56 |
| Return on Capital
| -49.69 | 18.98 | -- | -51.84 | -63.07 |
| Return on Assets
| -46.98 | -1,936.91 | -39.77 | -48.76 | -59.46 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.04 | 0.05 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Ventyx Biosciences (VTYX)
|
--
|
-51.84
|
-63.07
|
-34.17
|
-64.13
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-50.41
Lower than Peers by 10.07
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Ventyx Biosciences (VTYX)
|
-50.41
|
-54.27
|
-64.56
|
-34.25
|
-67.39
|
|
Peer Median
|
-40.33
|
--
|
--
|
--
|
--
|
ROA
-39.77
Lower than Peers by 8.53
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Ventyx Biosciences (VTYX)
|
-39.77
|
-48.76
|
-59.46
|
-32.71
|
-57.41
|
|
Peer Median
|
-31.24
|
--
|
--
|
--
|
--
|
EBIT Margin
-7,919.68
Lower than Peers by 7,837.09
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Ventyx Biosciences (VTYX)
|
-7,919.68
|
--
|
--
|
--
|
--
|
|
Peer Median
|
-82.60
|
--
|
--
|
--
|
--
|
Net Margin
-7,362.36
Lower than Peers by 7,271.06
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Ventyx Biosciences (VTYX)
|
-7,362.36
|
--
|
--
|
-2,302.04
|
507.55
|
|
Peer Median
|
-91.30
|
--
|
--
|
--
|
--
|
Cash Profit Margin
-0.01
Lower than Peers by 0.01
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Ventyx Biosciences (VTYX)
|
-0.01
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.00
|
--
|
--
|
--
|
--
|
Revenue Growth
34.57
Lower than Peers by 19.46
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Ventyx Biosciences (VTYX)
|
34.57
|
--
|
--
|
--
|
--
|
|
Peer Median
|
54.03
|
--
|
--
|
--
|
--
|
EBIT Growth
31.07
Higher than Peers by 32.09
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Ventyx Biosciences (VTYX)
|
31.07
|
28.63
|
-83.84
|
-35.25
|
-493.20
|
|
Peer Median
|
-1.02
|
--
|
--
|
--
|
--
|
Net Profit Growth
30.10
Higher than Peers by 37.64
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Ventyx Biosciences (VTYX)
|
30.10
|
29.97
|
-77.97
|
-29.47
|
-197.25
|
|
Peer Median
|
-7.53
|
--
|
--
|
--
|
--
|
EPS Growth
36.65
Higher than Peers by 22.42
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Ventyx Biosciences (VTYX)
|
36.65
|
0.42
|
-0.71
|
-0.08
|
-2.07
|
|
Peer Median
|
14.23
|
--
|
--
|
--
|
--
|
Book Value Growth
-31.97
Lower than Peers by 21.83
Year on year growth in book value per share
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Ventyx Biosciences (VTYX)
|
-31.97
|
--
|
--
|
--
|
--
|
|
Peer Median
|
-10.13
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Ventyx Biosciences (VTYX)
|
--
|
0.04
|
0.05
|
0.00
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.01
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Ventyx Biosciences (VTYX)
|
0.01
|
0.00
|
0.00
|
0.00
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
17.86
Higher than Peers by 12.05
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Ventyx Biosciences (VTYX)
|
17.86
|
17.97
|
11.87
|
20.21
|
21.41
|
|
Peer Median
|
5.81
|
--
|
--
|
--
|
--
|
Quick Ratio
17.86
Higher than Peers by 12.16
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Ventyx Biosciences (VTYX)
|
17.86
|
--
|
11.91
|
--
|
--
|
|
Peer Median
|
5.70
|
--
|
--
|
--
|
--
|
Interest Coverage
--
--
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Ventyx Biosciences (VTYX)
|
--
|
--
|
--
|
-24.02
|
-844.92
|
|
Peer Median
|
-2.09
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
34.53
Higher than Peers by 15.52
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Ventyx Biosciences (VTYX)
|
34.53
|
--
|
--
|
--
|
--
|
|
Peer Median
|
19.01
|
--
|
--
|
--
|
--
|
Asset Turnover
0.01
Lower than Peers by 0.06
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Ventyx Biosciences (VTYX)
|
0.01
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.06
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Ventyx Biosciences (VTYX)
|
--
|
-216.77
|
-310.52
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Ventyx Biosciences (VTYX)
|
--
|
1,203.86
|
2,365.59
|
4,310.73
|
35,082.26
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Ventyx Biosciences (VTYX)
|
--
|
-1.15
|
-0.76
|
-17.15
|
-11.21
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
5.25
Lower than Peers by 0.08
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Ventyx Biosciences (VTYX)
|
5.25
|
0.61
|
0.60
|
5.26
|
3.36
|
|
Peer Median
|
5.33
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Ventyx Biosciences (VTYX)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
-22.93
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Ventyx Biosciences (VTYX)
|
-22.93
|
0.35
|
0.45
|
-13.70
|
-8.13
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
1,005
Higher than Peers by 863
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-24
|
Dec-23
|
Dec-22
|
Dec-21
|
|---|---|---|---|---|---|
|
Ventyx Biosciences (VTYX)
|
1,005
|
--
|
--
|
--
|
--
|
|
Peer Median
|
142
|
--
|
--
|
--
|
--
|